-
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
February 11, 2025 -
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
February 6, 2025 -
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
February 4, 2025
Corporate Overview
Aclarion is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes and return patients to full, pain-free lives. The company’s first solution will address unmet needs in the low back and neck pain market. To learn more, visit www.aclarion.com.